Efficacy of low dose naltrexone for patients that suffer from comorbid depressive illness (Abstract)
Efficacy of low dose naltrexone for patients that suffer from comorbid depressive illness
The 15th Pacific Rim College of Psychiatrists Scientific Meeting
This study is a retrospective chart review meant to investigate the efficacy of low dose naltrexone (LDN) for the treatment of patients with co-morbid depression and collagen disease. At week 4, 80% of patients experienced a certain degree of improvement with LDN.